A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2006
11/23/2006	WO2006123674A1 Angiogenesis inhibitor containing amine derivative as active ingredient
11/23/2006	WO2006123644A1 Int6 PROTEIN INVOLVED IN HYPOXIA STRESS INDUCTION AND USE THEREOF
11/23/2006	WO2006123639A1 Pyrimidine derivative
11/23/2006	WO2006123631A1 Rna-containing composition
11/23/2006	WO2006123550A1 Prophylactic or therapeutic agent for inflammatory disease
11/23/2006	WO2006123517A1 Crystal polymorph of hydroxynorephedrin derivative hydrochloride
11/23/2006	WO2006123466A1 Drugs, food or drink for improving pancreatic functions
11/23/2006	WO2006123465A1 Drugs, food or drink for improving pancreatic functions
11/23/2006	WO2006123464A1 Drugs, food or drink for improving pancreatic functions
11/23/2006	WO2006123358A2 Stabilized atorvastatin-containing formulation
11/23/2006	WO2006123357A2 Oral controlled release composition containing levetiracetam
11/23/2006	WO2006123354A2 Oral pharmaceutical composition
11/23/2006	WO2006123254A2 Method for determining phytase activity
11/23/2006	WO2006123249A2 Novel oxadiazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
11/23/2006	WO2006123248A2 Improved methods and devices for delivering a therapeutic product to the ocular sphere of a subject
11/23/2006	WO2006123247A2 Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands
11/23/2006	WO2006123244A2 Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors
11/23/2006	WO2006123243A2 Pharmaceutical dosage forms comprising escitalopram in form of granules
11/23/2006	WO2006123242A1 1, 2, 4 -triazole derivatives as vasopressin antagonists
11/23/2006	WO2006123229A2 Novel heterocyclic derivatives
11/23/2006	WO2006123226A2 An inhibitor of mtor for inhibiting the formation of scar tissue
11/23/2006	WO2006123213A1 Modified release formulations of gliclazide
11/23/2006	WO2006123207A2 A kit for inhibiting gastric acid secretion having an adjustable amount of ph regulating agent
11/23/2006	WO2006123185A2 Sulphamides for treatment of cancer
11/23/2006	WO2006123183A2 Sulphone derivatives for treatment of cancer
11/23/2006	WO2006123182A2 Cyclohexyl sulphones for treatment of cancer
11/23/2006	WO2006123173A1 Gelatin-containing topical composition
11/23/2006	WO2006123145A1 Antifungal agents
11/23/2006	WO2006123125A1 Combinations of statins with glucocorticosteroids
11/23/2006	WO2006123121A1 Histone deacetylase inhibitors
11/23/2006	WO2006123113A2 Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
11/23/2006	WO2006123073A1 Sustained release solid pharmaceutical composition of 1-(2,3,4-trimethoxybenzyl)piperazine and a method for the preparation thereof
11/23/2006	WO2006123061A2 Fluorene derivatives, composition containing said derivatives and the use thereof
11/23/2006	WO2006123060A1 Novel food ingredient and products containing the same
11/23/2006	WO2006123031A2 Pharmaceutical composition comprising an oleaginous ointment and vitamin d or the derivatives thereof in solubilised form
11/23/2006	WO2006123020A1 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4
11/23/2006	WO2006122977A2 PROCESS FOR PREPARING 3α(β)-7α(β)-DIHYDROXY-6α(β)-ALKYL-5β-CHOLANIC ACID
11/23/2006	WO2006122954A2 Antiproliferative conjugates comprising hyaluronic acid and n-derivatives of glutamic acid
11/23/2006	WO2006122931A1 Beta-carboline derivatives and theri use as ghsr modulators
11/23/2006	WO2006122926A1 Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
11/23/2006	WO2006122925A2 Oral medicament based on a proton pump inhibitors
11/23/2006	WO2006122910A1 Halogenated quindoline dimers for the treatment of cancer
11/23/2006	WO2006122883A1 Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne
11/23/2006	WO2006122828A2 Optimized injection formulation for rna
11/23/2006	WO2006122806A2 1,3-dihydro-imidazo [4,5-c] quinolin-2-ones as lipid kinase inhibitors
11/23/2006	WO2006122800A1 Substituted benzo(d)isoxazol-3-yl amine compounds as analgesics
11/23/2006	WO2006122799A1 Benzo(d)isoxazol-3-yl-amine compounds and their use as vanilloid receptor ligands
11/23/2006	WO2006122788A1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR
11/23/2006	WO2006122777A2 Use of 2,5-disubstituted thiazol-4-one derivatives in drugs
11/23/2006	WO2006122776A1 Substituted benzo-condensed cycloheptanone derivatives and their use for producing drugs
11/23/2006	WO2006122773A1 Pentafluorosulphanyl-substituted compound and its use for producing medicaments
11/23/2006	WO2006122772A1 Salts of substituted allophanates and their use in drugs
11/23/2006	WO2006122771A2 Substituted benzo-condensed cyclohexanone derivatives and the use thereof for medicament production
11/23/2006	WO2006122770A1 Substituted spiro compounds and their use for producing pain-relief medicaments
11/23/2006	WO2006122769A2 Substituted spiro compounds and their use for producing pain-relief drugs
11/23/2006	WO2006122716A1 Use of ether-linked lysophosphatidylcholines and alkylphosphocholines for the treatment of papilloma virus induced warts and sarcoids
11/23/2006	WO2006122685A1 Compositions for the treatment of psoriasis
11/23/2006	WO2006122680A1 Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (pge2)
11/23/2006	WO2006122668A1 Active ingredient combinations of glucosyl glycerides and creatine and/or creatinine
11/23/2006	WO2006122661A1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors
11/23/2006	WO2006122652A2 Thiosuccinic acid derivatives and the use thereof
11/23/2006	WO2006122631A1 2-amino-4-phenylquinazoline derivates and their use as hsp90 modulators
11/23/2006	WO2006122546A1 Non-peptidic inhibitors of akap/pka interaction
11/23/2006	WO2006122485A1 A pharmaceutical composition for treating diabetes and process thereof
11/23/2006	WO2006122464A1 An oligonucleotide or its functional homologue, a composition comprising the same and a method for treating b cell neoplasm
11/23/2006	WO2006122463A1 Oligonucleotides or their functional homologues, a composition comprising the same and a method of treating b cell neoplasm
11/23/2006	WO2006122462A1 A oral preparation comprising dyclonine hydrochloride
11/23/2006	WO2006122454A1 A pharmaceutical composition for treating diabetes and preparation method thereof
11/23/2006	WO2006122431A1 Triazine compounds and compositions thereof for the treatment of cancers
11/23/2006	WO2006122414A1 Depot for sustained and controlled delivery of methotrexate
11/23/2006	WO2006122409A1 Antimicrobial molecules and their uses
11/23/2006	WO2006122408A1 Bir domain binding compounds
11/23/2006	WO2006122403A1 Quinoline derivatives as ep4 antagonists
11/23/2006	WO2006122401A1 Negative regulation of nk cell functions by eat-2, a sap-related adaptor expressed in innate immune cells
11/23/2006	WO2006122353A1 Methods and compositions for the treatment of pain
11/23/2006	WO2006110884A3 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists
11/23/2006	WO2006110175A9 Combined treatment with bortezomib and an epidermal growth factor receptor kinase inhibitor
11/23/2006	WO2006110173A3 Novel compounds
11/23/2006	WO2006108155A3 Process for the preparation of anastrozole
11/23/2006	WO2006106437A3 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
11/23/2006	WO2006105217A3 Spirocyclic thrombin receptor antagonists
11/23/2006	WO2006103056A3 Topical product containing betaine for preventing and treating nappy rash
11/23/2006	WO2006101783A8 Compounds and compositions as protein kinase inhibitors
11/23/2006	WO2006099410A3 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
11/23/2006	WO2006098918A3 Substituted gamma lactams as therapeutic agents
11/23/2006	WO2006096861A9 METHODS FOR IDENTIFYING TUMORS RESPONSIVE TO TREATMENT WITH HER DIMERIZATION INHIBITORS (HDIs)
11/23/2006	WO2006094012A3 Pentacyclic alkaloid compounds and methods of use thereof
11/23/2006	WO2006091862A3 Cytokine inhibitors and their use in therapy
11/23/2006	WO2006089168A3 Methods for modulating ion channels
11/23/2006	WO2006089120A3 Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury
11/23/2006	WO2006087306A3 Diazabicyclic aryl derivatives and their use as cholinergic ligands at the nicotinic acetylcholine receptors
11/23/2006	WO2006084870A3 Alkyl substituted homopiperazine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/23/2006	WO2006084757A3 Combination of ca/mg salt of valsartan with an antidiabetic agent
11/23/2006	WO2006084015A3 Raf inhibitor compounds and methods
11/23/2006	WO2006083970A3 Tumor necrosis factor inhibitors
11/23/2006	WO2006083780A3 Glucuronidated nebivolol
11/23/2006	WO2006083779A3 Pharmaceutical composition comprising hydroxylated nebivolol
11/23/2006	WO2006081034A3 Anti-inflammatory medicaments
11/23/2006	WO2006076317A3 Aminophenyl derivatives as selective androgen receptor modulators
11/23/2006	WO2006075011A3 Glycine reuptake inhibitors for treating drug and alcohol dependence

1 ... 3993 3994 3995 3996 3997 3998 3999 4000 4001 4002 4003 4004 4005 4006 4007 4008 4009 4010 4011 4012 4013 ... 7860